샘플 요청 목록

 카트 문의
시장보고서
상품코드
1526299

세계의 COVID-19 검사 시장

COVID-19 Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 1417 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

COVID-19 검사 세계 시장은 2030년까지 58억 달러에 이를 전망

2023년에 199억 달러로 추정되는 COVID-19 검사 세계 시장은 2030년에는 58억 달러에 이르고, 분석 기간인 2023-2030년간 CAGR은 ―16.1%를 나타낼 전망입니다. 본 보고서에서 분석한 부문 중 하나인 RT-PCR 어세이 키트는 CAGR-16.9%를 나타내고, 분석 기간 종료시에는 39억 달러에 이를 것으로 예측됩니다. Immunoassay Test Strips/Cassettes 부문의 성장률은 분석 기간중 CAGR-14.2%로 추정됩니다.

미국 시장은 추정 50억 달러, 중국은 CAGR -31.0%로 성장 예측

미국의 COVID-19 검사 시장은 2023년에 50억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 5,690만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은―31.0%입니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각―15.1%와―14.4%를 나타낼 것으로 예측됩니다. 유럽에서는 독일 CAGR이 약-13.8%를 나타낼 것으로 예측됩니다.

세계 COVID-19 검사 시장 - 주요 동향 및 촉진요인 요약

COVID-19 검사란 코로나19의 원인인 SARS-CoV-2 바이러스에 감염되었는지 여부를 판단하는 방법과 과정을 말합니다. 주로 바이러스 자체의 존재를 검출하는 진단 검사와 바이러스에 반응하여 생성되는 항체를 확인하여 과거 감염 여부를 확인하는 혈청학적 검사 두 가지가 있습니다. 진단 검사로는 중합효소연쇄반응(PCR) 검사가 있으며, 정확도가 높아 바이러스 검출의 표준으로 여겨지고 있습니다. 신속 항원 검사는 빠른 결과를 얻을 수 있지만 PCR 검사보다 정확도가 낮으며 주로 고처리량 환경에서 스크리닝 목적으로 사용됩니다.

팬데믹을 겪으면서 수요 증가와 다양한 과제에 대응하기 위해 상황은 빠르게 진화하고 있습니다. 검사 기술의 혁신은 정확도 향상, 시간 단축, 접근성 향상에 중점을 두고 있습니다. 예를 들어, 현장 검사 및 재택 검사 키트의 개발로 전통적인 의료 시설 이외의 장소에서 광범위한 검사가 가능해졌습니다. 이러한 발전으로 보다 광범위하고 빈번한 검사가 가능해졌으며, 이는 바이러스 확산을 추적하고 적시에 격리 및 치료 전략을 실행하는 데 매우 중요합니다. 또한 바이러스가 변이함에 따라 새로운 변종에 대한 민감도를 보장하고 검사의 신뢰성과 유효성을 유지하기 위해 지속적인 연구와 검사에 대한 적응이 필요합니다.

COVID-19 검사 시장의 성장은 기술 발전, 정부 정책, 소비자 행동 변화 등 여러 가지 요인에 의해 주도되고 있습니다. 기술 혁신은 대규모 배포가 가능한 보다 신속하고 정확한 검사의 개발로 이어졌으며, 이는 발병을 관리하고 안전한 사회적 교류를 촉진하는 데 필수적입니다. 정부 정책과 자금 지원은 시장에 큰 영향을 미치고 있으며, 공중 보건 전략을 지원하기 위해 검사 인프라에 대한 대규모 투자가 이루어지고 있습니다. 또한, 대유행 기간 동안 일반 대중의 의식과 행동이 크게 변화했습니다. 현재 정기적인 COVID-19 검사를 포함한 개인 건강 모니터링 및 예방 습관에 대한 수요가 증가하고 있습니다. 이러한 변화는 검사 시장의 지속적인 성장을 가속하고 검사가 세계 보건의 중요한 요소로 남을 수 있도록 보장합니다.

조사 대상 기업 예(합계 547건)

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 최근 시장 동향
  • 주요 기업
  • 시장 동향과 과제
  • 크리스 파
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.08.09

Global COVID-19 Testing Market to Reach US$5.8 Billion by 2030

The global market for COVID-19 Testing estimated at US$19.9 Billion in the year 2023, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Immunoassay Test Strips/Cassettes segment is estimated at -14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at -31.0% CAGR

The COVID-19 Testing market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.9 Million by the year 2030 trailing a CAGR of -31.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of -15.1% and -14.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately -13.8% CAGR.

Global Covid-19 Testing Market - Key Trends and Drivers Summarized

COVID-19 testing refers to the methods and processes used to determine whether a person is infected with the SARS-CoV-2 virus, which causes COVID-19. There are primarily two types of tests: diagnostic tests, which detect the presence of the virus itself, and serological tests, which identify antibodies produced in response to it, indicating past infection. Diagnostic tests include polymerase chain reaction (PCR) tests, which are highly accurate and are considered the gold standard for detecting the virus. Rapid antigen tests provide quicker results but are less accurate than PCR tests and are used primarily for screening purposes in high-throughput environments.

Throughout the pandemic, the landscape of COVID-19 testing has evolved rapidly to meet increasing demands and address various challenges. Innovations in testing technology have focused on increasing accuracy, reducing turnaround times, and enhancing accessibility. For instance, developments in point-of-care testing and at-home testing kits have allowed for broader testing outside traditional healthcare facilities. These advancements have enabled more extensive and frequent testing, which is crucial for tracking the spread of the virus and implementing timely isolation and treatment strategies. Moreover, as the virus mutates, ongoing research and adaptation in testing are necessary to ensure sensitivity to new variants, maintaining the reliability and effectiveness of tests.

The growth in the COVID-19 testing market is driven by several factors, including technological advancements, government policies, and changes in consumer behavior. Technological innovations have led to the development of faster, more accurate tests that can be deployed at scale, which are essential for managing outbreaks and facilitating safe social interactions. Government policies and funding have significantly influenced the market, with massive investments in testing infrastructure to support public health strategies. Additionally, public awareness and behavior have changed markedly during the pandemic; there is now a higher demand for personal health monitoring and preventive practices, which includes regular COVID-19 testing. This shift has encouraged continuous growth in the testing market, ensuring that it remains a critical component of global health.

Select Competitors (Total 547 Featured) -

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Types of COVID-19 Testing
    • Different Types of Coronavirus Tests
    • Performance Analysis of COVID-19 Tests
    • Rapid Tests Help in Controlling the Virus
    • Massive Testing to Become a Way of Life
    • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
    • Select Approved COVID-19 Molecular Assay Tests
    • Immunoassays to Witness Fastest Growth
    • Increasing Demand for Antibody Tests
    • How Antibody (Serology) Tests Were Approved and Developed
    • List of US FDA Approved Antigen Tests
    • Nasopharyngeal/Oropharyngeal Swabs Remain Primary Sample Type
    • Diagnostic Laboratories Constitute the Largest End-use Segment
  • RECENT MARKET ACTIVITY
    • Recent Launches
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS AND ISSUES
    • Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics
    • Increasing Point-of-Care Molecular Testing
    • Accelerated Development and Faster Adoption of New Technologies
    • Expansion of Manufacturing Capacity in Asia and Shift of Supply
    • Positioning for the Future
    • Some Innovative Testing Methods for COVID-19:
  • CRISPR
    • Bioluminescence Testing
    • Lab-on-chip Testing
    • LAMpore Kits
    • Covid-19 NudgeBox Test by DNANudge
    • High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Point-of-Care Tests Witness Rapid Growth
    • Innovations and Approvals
    • Portable PoC Test with a Smartphone Reader
    • Saliva Test
    • FDA Approves First Molecular Test for Asymptomatic Patients
    • LumiraDx SARS-CoV-2 Antigen Test
    • Integration of Sophisticated Technology to Drive Market Growth
    • Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing
    • A Rapid Genomics Strategy to Trace Coronavirus
    • The pioneering of Rapid Genomics
    • Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic
    • Digital Technologies Gaining Adoption Amid COVID-19
    • List of COVID-19 Contact Tracing Apps
    • Amazon Offers FDA-Approved COVID-19 Test
    • Alliance of BMGF and Life Science Companies Pledge to Improve Access
    • Ensuring the Perfect Mix of COVID-19 Testing
    • Testing Rate & Average Turnaround Time to Results as Key Metrics
    • Growing Significance of Pooled Testing
    • Participation of Public & Private Sector
    • Avoiding Supply Mismatch
    • COVID-19 Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Market Prospects and Outlook
    • US and Europe Dominate, Asia-Pacific to Witness Fastest Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for RT-PCR Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for RT-PCR Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Test Strips/Cassettes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Immunoassay Test Strips/Cassettes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Nasopharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Nasopharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Oropharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Oropharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nasal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Nasal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Specimen Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Specimen Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World 7-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 21: World COVID-19 Testing Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • Government of Ontario Introduces Covid-19 Screening Tests at Toronto Pearson International Airport
    • New Federal Rule in Canada for Air Passengers' COVID-19 Tests
    • TABLE 28: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SPAIN
    • TABLE 78: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Spain 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Spain 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • RUSSIA
    • TABLE 84: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Russia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Russia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • AUSTRALIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Australia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Australia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • INDIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 113: India 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 115: India 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 119: South Korea 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 121: South Korea 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
    • Authorities Succeed In Successfully Evading the Virus Impact
    • Widespread Roll Out of Testing Laboratories Yields Results
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • LATIN AMERICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2024 & 2030
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 131: Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 133: Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ARGENTINA
    • TABLE 136: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 137: Argentina 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 139: Argentina 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • BRAZIL
    • TABLE 142: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 143: Brazil 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 145: Brazil 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • MEXICO
    • TABLE 148: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 149: Mexico 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 151: Mexico 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 154: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 155: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • MIDDLE EAST
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 161: Middle East 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2024 & 2030
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 163: Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 167: Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • IRAN
    • TABLE 168: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 169: Iran 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 173: Iran 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ISRAEL
    • TABLE 174: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 175: Israel 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 179: Israel 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SAUDI ARABIA
    • TABLE 180: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 181: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • UNITED ARAB EMIRATES
    • New Testing Facilities Open Up in the UAE
    • TABLE 186: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 187: UAE 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 191: UAE 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 192: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 193: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • AFRICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • COVID-19 Testing Benefits from Existing TB and HIV Laboratory Systems
    • RDTs Arrive in African Countries
    • TABLE 198: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 199: Africa 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 203: Africa 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제